CompletedPhase 1Progressive MSNCT01381354

What it found

Result in a paper, not read yet

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Progressive exercise
  • Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV
  • Modified paleolithic diet
  • Omega-3 fatty acids
  • Full Spectrum vitamin
  • Essential - hydroxytyrosol
  • Maltodextrin fiber supplement
  • Magnesium
  • Niacinamide
  • Methylcobalamin
  • Taurine
  • Creatine
  • Thiamine ion
  • Riboflavin
  • N acetylcysteine
  • Lipoic acid, alpha
  • L acetyl carnitine
  • methyl folate
  • coenzyme Q
  • meditation
  • self massage
  • learning
  • Wax, emulsifying

What it measured

Main measures

  • Fatigue severity scale

    Baseline, 3 M, 6M, 9M,12 M

    Fatigue

Other measures (42)

  • 25 foot walk

    baseline, 3M, 6M, 9M, 12M, 18M, 24M 36M

    Walking and mobility
  • Short Form 36

    baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36 M

  • Mood scales

    Baseline, 3 M, 6M, 9M, 12M

    Mood and sleep
  • Cognitive Scales

    baseline, 3 M, 6M, 9M, 12 M

    Thinking and memory
  • Medical Symptoms Questionnaire

    baseline, 1 M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M, 18M, 24M, 36M

  • Side effects log

    Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M

    Physical functionSafety
  • MS Function

    Baseline, 3 M, 6M, 9M, 12M, 18M, 24M, 36M

  • Multiple Sclerosis Spasticity Scale-88

    Baseline, 3M, 6M,9M and 12M, 18M, 24M, 36M

    Spasticity
  • Daily log

    Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M

    Physical function
  • Vitamin log

    Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M

Who could take part

Progressive MS · 18 to 65

Inclusion Criteria: * Secondary or primary progressive multiple sclerosis * Some level of gait disability * Tolerance for test electrical therapy session * Successful completion of two week Run-IN phase completing the daily logs - * Demonstrating > 80% compliance with dietary and behavioral interventions Exclusion Criteria: * Antiplatelet or blood thinning medication * Cognitive disability or psychiatric disorder making compliance with study interventions difficult * Implanted electronic medical device * Change in medication in the prior three months * Active cancer treatment (skin basal cell or squamous cancer is not an exclusion criteria)

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of gait and fatigue disability in the setting of secondary and primary progressive multiple sclerosis with gait disability.

Papers

Loading reviews and guidelines…

Related trials

History

    1. Started

      Oct 2010

    2. Main results due

      Feb 2016

    3. Finished

      May 2016

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error